Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02613052Completed
Randomised, single-blind trial of albumin (human) and propofol injection (veterinary) (3 arms), sponsored by University of California, San Diego. Primary endpoint: Qualitative enhancement in right atrial opacification. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02613052.